VEGFA and Abnormal retinal morphology: This finding was quite similar to those from recent studies performed on ziv-aflibercept on a larger number of patients [32, 33] that discussed the application of ziv-aflibercept in different retinal diseases and detected a reasonable safety profile for the drug comparable with those of other anti-VEGF agents.